Skip to main content

Biopharma Startups

Updated July 2026

Companies in the biopharma sector developing innovative solutions and technologies.

Explore 854 recently funded biopharma companies with verified founder contact information and fundraising data.

Total Companies
854
Total Funding
$1.2B
Avg Funding
$47.0M
Global Reach
8
countries

Top Cities for Biopharma

Budapest
Cambridge
Solna
Buffalo
Copenhagen
Watertown

Recently Funded Companies

Export
Budapest, Hungary

Novamigra Therapeutics is a biotechnology research organisation engaged in advancing a novel approach to migraine prophylaxis.

$3.5M raised
Jan 2026

Founder Contacts

30,000+ verified contacts

Cambridge, United States

Foghorn Therapeutics is developing therapies based on a system that directs which genes our cells express,

$50.0M raised
Jan 2026

Founder Contacts

30,000+ verified contacts

Solna, Sweden

AnaCardio is a clinical stage biopharmaceutical company developing novel drugs to treat heart failure.

$18.4M raised
Jan 2025

Founder Contacts

30,000+ verified contacts

Buffalo, United States

MimiVax is a developer of immunotherapeutic vaccines and targeted therapies used to control tumor growth and recurrence.

Jan 2024

Founder Contacts

30,000+ verified contacts

Copenhagen, Denmark

Muna Therapeutics discovers and develops therapies that slow or stop neurodegenerative diseases such as alzheimer’s and parkinson's.

$1.0M raised
Jan 2026

Founder Contacts

30,000+ verified contacts

Watertown, United States

Diagonal Therapeutics is a biotechnology startup that develops targeted therapies for cancer and genetic diseases.

$125.0M raised
Jan 2026

Founder Contacts

30,000+ verified contacts

Milano, Italy

Bio-tech company producing functional and bioactive ingredients

$117K raised
Jan 2026

Founder Contacts

30,000+ verified contacts

Seattle, United States

Designing innovative technologies focused on accelerating global access to biotherapeutics.

Jan 2026

Founder Contacts

30,000+ verified contacts

Oxford, United Kingdom

Genomics plc aiming to lead the genomic transformation of healthcare.

$44.6M raised
Jan 2024

Founder Contacts

30,000+ verified contacts

Toulouse, France

SWEETECH is a deeptech startup developed a patented platform for environmentally friendly production of oligosaccharides via fermentation.

$2.6M raised
Jan 2026

Founder Contacts

30,000+ verified contacts

San Diego, United States

Biotechnology company developing pharmaceutical therapies for nerve regeneration in the central nervous system.

$2.5M raised
Jan 2026

Founder Contacts

30,000+ verified contacts

Las Vegas, United States

Biowound Solutions is a healthcare company that develops and offers treatment product for chronic wounds.

$4.5M raised
Jan 2024

Founder Contacts

30,000+ verified contacts

South San Francisco, United States

Perceive Biotherapeutics is a biotechnology company pioneering novel technologies and therapeutics in ophthalmology.

$78.0M raised
Jan 2023

Founder Contacts

30,000+ verified contacts

Palo Alto, United States

Immune-Onc Therapeutics is a newly established biopharmaceutical company that develops therapeutic antibodies for cancer treatment.

$25.0M raised
Jan 2023

Founder Contacts

30,000+ verified contacts

San Francisco, United States

Moonwalk Biosciences operates a genomic medicine company that aims to provide a new class of precision epigenetic medications.

$57.0M raised
Jan 2024

Founder Contacts

30,000+ verified contacts

Geleen, The Netherlands

Matisse Pharmaceuticals is a biotechnology company dedicated to development of pharmaceutical therapies.

$3.9M raised
Jan 2024

Founder Contacts

30,000+ verified contacts

New York, United States

Epikast provides technology-enabled commercial and clinical services for the biopharmaceutical industry.

$2.2M raised
Jan 2026

Founder Contacts

30,000+ verified contacts

Houston, United States

Coya Therapeutics is a T Reg platform company addressing neurodegenerative, autoimmune, and metabolic diseases

$11.1M raised
Jan 2026

Founder Contacts

30,000+ verified contacts

Naples, United States

Enalare Therapeutics is a clinical stage biopharmaceutical company dedicated to developing novel therapies.

$2.5M raised
Jan 2025

Founder Contacts

30,000+ verified contacts

San Carlos, United States

Vaxcyte focuses on developing vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide.

$632.5M raised
Jan 2026

Founder Contacts

30,000+ verified contacts

Chicago, United States

Prenosis develops data-driven diagnostic tools and precision medicine solutions for acute care conditions.

$20.0M raised
Jan 2026

Founder Contacts

30,000+ verified contacts

Houston, United States

Pranax is a biotechnology company that develops and commercializes regenerative medicine solutions centered on exosome technology.

$17.0M raised
Jan 2026

Founder Contacts

30,000+ verified contacts

New York, United States

Liberation Bioindustries is a biotech firm that develops an industrial biotechnology system for agriculture.

$60.2M raised
Dec 2025

Founder Contacts

30,000+ verified contacts

Boston, United States

Rowan is a molecular design and simulation tool used by scientists for modeling and analyzing molecular structures and behavior.

$2.1M raised
Dec 2024

Founder Contacts

30,000+ verified contacts

San Diego, United States

Bloom Science is a clinical-stage central nervous system company developing novel therapeutics for patients with neurological disorders.

$12.0M raised
Dec 2021

Founder Contacts

30,000+ verified contacts

Showing 601 to 625 of 854 companies

About the Biopharma Startup Ecosystem

The biopharma sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Biopharma

Biopharma companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The biopharma sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Biopharma Funding Breakdown

Here is how funding is distributed among the 854 biopharma companies tracked in the VCBacked database.

Average Funding
$47.0M
Total Funding Tracked
$1.2B
Countries Represented
8

Distribution by Funding Stage

Other25 companies

Top Cities for Biopharma

1.San Diego
2 companies$14.5M
2.New York
2 companies$62.4M
3.Houston
2 companies$28.1M
4.Budapest
1 companies$3.5M
5.Cambridge
1 companies$50.0M

Related Industries

Companies in the biopharma sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Biopharma Startups?

Perfect for: B2B sales teams targeting biopharma companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked

854 Biopharma Startups (2026) — Recently Funded Companies, Investors & Rounds — Page 25 | VCBacked